Novartis employs more than 119 000 associates worldwide. The ability to attract, grow and keep talented people is vital for us to execute our strategy and keep developing innovative products that produce better results for patients. In the context of an increasingly challenging healthcare environment and rapid change at Novartis, we are reinforcing our culture, boosting our associates’ skills and building a diverse workforce with talented leaders.
Under the leadership of Chief Executive Officer Joseph Jimenez, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors.
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 – Press 1 for reporting an adverse event. Fax: 002 02 26031702. E-Mail: [email protected]